모든 사진(1)
크기 선택
보기 변경
5 MG
₩474,107
25 MG
₩1,554,371
About This Item
실험식(Hill 표기법):
C21H18O5
CAS Number:
Molecular Weight:
350.36
MDL number:
UNSPSC 코드:
12352200
PubChem Substance ID:
NACRES:
NA.77
추천 제품
분석
≥98% (HPLC)
양식
solid
저장 조건
protect from light
색상
white
solubility
DMSO: 9 mg/mL
저장 온도
2-8°C
SMILES string
O=C1Oc2cc3occc3c(OCCCCOc4ccccc4)c2C=C1
InChI
1S/C21H18O5/c22-20-9-8-16-19(26-20)14-18-17(10-13-24-18)21(16)25-12-5-4-11-23-15-6-2-1-3-7-15/h1-3,6-10,13-14H,4-5,11-12H2
InChI key
KINMYBBFQRSVLL-UHFFFAOYSA-N
생화학적/생리학적 작용
5-(4-Phenoxybutoxy)psoralen (PAP-1) is derived from 5-methoxypsoralen, a natural compound. PAP-1 show higher selectivity for Kv1.3 (voltage-gated potassium channels) than other Kv1 family members. Kv1.3 is predominant on cell membranes of activated effector memory T-cells. Inhibition of Kv1.3 results in membrane depolarization. In rat models, PAP-1 is known to delay the onset of diabetes.[1] It might be used in the treatment of psoriasis and effector memory T cells mediated autoimmune diseases.[2] Oral, intraperitoneal and topical administration of PAP-1 prevents allergic contact dermatitis induced by oxazolone.[3]
Selective inhibitor of Kv1.3, voltage-gated K+ channel.
Selective inhibitor of Kv1.3, voltage-gated K+ channel. PAP-1 (EC50=2 nM) potently inhibits human T effector memory cell proliferation and delayed hypersensitivity. Effective orally or intraperitoneally. 5-(4-Phenoxybutoxy)psoralen has 23-fold selectivity for Kv1.3 over Kv1.5, and 33-125-fold selectivity over other Kv1 family channels.
특징 및 장점
This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
신호어
Danger
유해 및 위험 성명서
예방조치 성명서
Hazard Classifications
Resp. Sens. 1
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
개인 보호 장비
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
가장 최신 버전 중 하나를 선택하세요:
시험 성적서(COA)
Lot/Batch Number
4-Phenoxybutoxy-substituted heterocycles-A structure-activity relationship study of blockers of the lymphocyte potassium channel Kv1. 3
Bodendiek SB, et al.
European Journal of Medicinal Chemistry, 44(5), 1838-1852 (2009)
Pharmacokinetics, toxicity, and functional studies of the selective Kv1. 3 channel blocker 5-(4-phenoxybutoxy) psoralen in rhesus macaques
Pereira LE, et al.
Exp. Biol. Med, 232(10), 1338-1354 (2007)
Identification of phase-I metabolites and chronic toxicity study of the Kv1. 3 blocker PAP-1 (5-(4-phenoxybutoxy) psoralen) in the rat
Hao B, et al.
Xenobiotica, 41(3), 198-211 (2011)
Dai-Chao Ma et al.
Experimental neurology, 332, 113399-113399 (2020-07-12)
After cerebral ischemia/reperfusion injury, pro-inflammatory M1-like and anti-inflammatory M2-like phenotypes of microglia are involved in neuroinflammation, in which NLRP3 inflammasome plays an essential role. Kv1.3 channel has been recognized as neuro-immunomodulatory target, but it is not clear as to its
Joaquim Bobi et al.
Translational research : the journal of laboratory and clinical medicine, 224, 40-54 (2020-06-12)
The modulation of voltage-gated K+ (Kv) channels, involved in cell proliferation, arises as a potential therapeutic approach for the prevention of intimal hyperplasia present in in-stent restenosis (ISR) and allograft vasculopathy (AV). We studied the effect of PAP-1, a selective
문서
We offer many products related to potassium channels for your research needs.
활성 필터
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.
